Pyrazine compounds as phosphodiesterase 10 inhibitors
US8053438B2 · kind B2 · utility
12Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2009 |
| Grant date | Nov 8, 2011 |
| Priority date | — |
| Expiry date | Nov 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyrazine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.